Clinical Trials Browser

Phase 2 × Osteosarcoma × Bevacizumab × Clear all

NCT06041490 2023-09-18

Adjuvant Therapy for High-risk Hepatocellular Carcinoma Post Liver Transplantation

Phase 2 Not yet recruiting

GastrointestinalSarcoma

Carcinoma, Hepatocellular, Recurrence, Osteosarcoma